Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced positive top-line Phase II study results for its novel ...

The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...

Net income of $27.2 million on $73.1 million in revenue, compared to a net loss of $6.1 million on $43.7 million in revenue in Q1 2024 <l ...

WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines ...

Net income of $27.2 million on $73.1 million in revenue, compared to a net loss of $6.1 million on $43.7 million in revenue in Q1 2024 Retired our higher-interest ...